$46.81
-0.75-1.58%
At Close: -
$46.82
0.01000.02%
After Hours: Jul 19, 6:04 PM EDT
15 minutes delayed
Comments
Loading...
Exact Sciences
EXASNASDAQ
Exact Sciences (NASDAQ:EXAS) Stock, Insider Trading Activity
Exact Sciences: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Exact Sciences Corp Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Exact Sciences Corp
Institutional Shares Held
144.190M
Institutional Percentage Held
78.1%
| May 02, 2024 | D. Scott Coward | — | 151.00 | $60.15 | -$4.03K | GRANT | 0.31% | 49.34K | Apr 30 - May 01 | View |
| May 02, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 863.00 | $45.09 | $13.07K | GRANT | 1.85% | 47.61K | Apr 30 - May 01 | View |
| May 02, 2024 | James Herriott | SVP, GENERAL COUNSEL & SEC | 741.00 | $45.09 | $19.45K | GRANT | 7.19% | 11.05K | Apr 30 - May 01 | View |
| May 02, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 862.00 | $45.09 | $13.04K | GRANT | 6.89% | 13.38K | Apr 30 - May 01 | View |
| May 02, 2024 | Brian Baranick | EVP, GM., PRECISION ONCOLOGY | 108.00 | $60.15 | -$6.62K | GRANT | 0.79% | 13.73K | Apr 30 - May 01 | View |
| May 02, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 824.00 | $45.09 | $15.12K | GRANT | 1.06% | 78.34K | Apr 30 - May 01 | View |
| May 02, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 116.00 | $60.15 | -$6.14K | GRANT | 0.75% | 15.56K | Apr 30 - May 01 | View |
| May 02, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 2.04K | $45.09 | -$48.22K | GRANT | 0.17% | 1.18M | Apr 30 - May 01 | View |
| Apr 03, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.52% | 77.51K | Apr 01 | View |
| Apr 03, 2024 | Brian Baranick | EVP, GM., PRECISION ONCOLOGY | -924.00 | $79.43 | -$73.39K | SELL | -6.35% | 13.63K | Apr 02 | View |
| Apr 01, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.45% | 79.51K | Mar 28 | View |
| Mar 04, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 2.57K | $59.32 | -$127.78K | SELL-OPTIONS | 19.97% | 15.44K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Daniel J Levangie | DIRECTOR | -5.00K | $57.50 | -$287.50K | SELL | -17.87% | 22.98K | Mar 01 | View |
| Mar 04, 2024 | James Herriott | GENERAL COUNSEL | 1.03K | $59.32 | -$51.13K | SELL-OPTIONS | 11.08% | 10.31K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.88K | $59.32 | -$143.08K | SELL-OPTIONS | 29.87% | 12.52K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | James Edward Doyle | DIRECTOR | -2.00K | $57.50 | -$115.00K | SELL | -3.84% | 50.11K | Mar 01 | View |
| Mar 04, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 2.88K | $59.32 | -$143.08K | SELL-OPTIONS | 6.56% | 46.75K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 9.87K | $59.32 | -$490.64K | SELL-OPTIONS | 0.75% | 1.32M | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 2.06K | $59.32 | -$102.27K | SELL-OPTIONS | 2.59% | 81.51K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 2.40K | $59.32 | -$137.80K | SELL-OPTIONS | 19.76% | 14.55K | Feb 29 - Mar 01 | View |
| Feb 28, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 2.08K | $56.89 | -$106.90K | SELL-OPTIONS | 19.22% | 12.87K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | James Herriott | GENERAL COUNSEL | 864.00 | $56.89 | -$44.60K | SELL-OPTIONS | 10.27% | 9.28K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 4.03K | $56.89 | -$207.53K | SELL-OPTIONS | 10.12% | 43.87K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.99K | $56.89 | -$154.17K | SELL-OPTIONS | 44.99% | 9.64K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 6.92K | $56.89 | -$356.30K | SELL-OPTIONS | 0.53% | 1.31M | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 2.07K | $56.89 | -$106.95K | SELL-OPTIONS | 2.68% | 79.46K | Feb 26 - Feb 27 | View |
| Feb 28, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 1.93K | $56.89 | -$115.32K | SELL-OPTIONS | 18.85% | 12.15K | Feb 26 - Feb 27 | View |
| Feb 26, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -1.02K | $59.72 | -$60.97K | SELL | -1.30% | 77.38K | Feb 23 | View |
| Feb 23, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 1.02K | $59.78 | -$60.56K | GRANT | 10.45% | 10.80K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | James Herriott | GENERAL COUNSEL | 290.00 | $59.78 | -$17.40K | GRANT | 3.57% | 8.42K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.36K | $59.78 | -$80.76K | GRANT | 25.72% | 6.65K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 1.36K | $59.78 | -$80.70K | GRANT | 3.54% | 39.84K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | D. Scott Coward | DIRECTOR | 1.37K | $59.78 | -$39.63K | GRANT | 2.87% | 49.19K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 11.67K | $59.78 | -$691.36K | GRANT | 0.93% | 1.26M | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 1.02K | $59.78 | -$60.56K | GRANT | 1.32% | 78.41K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 941.00 | $59.78 | -$65.34K | GRANT | 10.14% | 10.22K | Feb 21 - Feb 22 | View |
| Feb 22, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 1.17K | $61.50 | -$66.30K | SELL-OPTIONS | 13.60% | 9.78K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | James Herriott | GENERAL COUNSEL | 449.00 | $61.50 | -$25.52K | SELL-OPTIONS | 5.85% | 8.13K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.62K | $61.50 | -$91.82K | SELL-OPTIONS | 44.13% | 5.29K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | D. Scott Coward | DIRECTOR | 1.54K | $61.50 | -$43.42K | SELL-OPTIONS | 3.33% | 47.82K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 5.40K | $61.50 | -$305.96K | SELL-OPTIONS | 0.43% | 1.25M | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 1.17K | $61.50 | -$66.36K | SELL-OPTIONS | 1.53% | 77.38K | Feb 20 - Feb 21 | View |
| Feb 22, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 834.00 | $61.50 | -$55.04K | SELL-OPTIONS | 9.87% | 9.28K | Feb 20 - Feb 21 | View |
| Feb 16, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 1.06K | $61.43 | -$59.34K | SELL-OPTIONS | 14.71% | 8.30K | Feb 14 - Feb 15 | View |
| Feb 16, 2024 | James Herriott | GENERAL COUNSEL | 530.00 | $45.73 | -$23.82K | SELL-OPTIONS | 7.74% | 7.38K | Oct 31 - Feb 15 | View |
| Feb 16, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.08K | $61.43 | -$115.98K | SELL-OPTIONS | 158.72% | 3.40K | Feb 14 - Feb 15 | View |
| Feb 16, 2024 | D. Scott Coward | DIRECTOR | 2.60K | $61.43 | -$84.53K | SELL-OPTIONS | 5.94% | 46.27K | Feb 14 - Feb 15 | View |
| Feb 16, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 17.05K | $45.73 | -$887.33K | SELL-OPTIONS | 1.39% | 1.25M | May 01 - Feb 15 | View |
| Feb 16, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 1.07K | $61.43 | -$59.28K | SELL-OPTIONS | 1.42% | 75.91K | Feb 14 - Feb 15 | View |
| Jan 04, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -2.00K | $73.50 | -$147.00K | SELL | -2.60% | 74.85K | Jan 02 | View |
| Jan 04, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | -879.00 | $73.50 | -$64.61K | SELL | -9.59% | 8.29K | Jan 02 | View |
| Dec 18, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.54% | 76.85K | Dec 14 | View |
| Oct 13, 2023 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 15.21K | $48.25 | -$843.55K | SELL-OPTIONS | 66.19% | 38.18K | May 01 - Oct 12 | View |
| Sep 06, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -6.89K | $84.36 | -$379.62K | SELL | -8.04% | 78.85K | Sep 01 | View |
| Aug 23, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | -29.24K | $58.80 | -$2.47M | SELL | -95.70% | 1.31K | May 02 - Aug 21 | View |
| Aug 08, 2023 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 1.36K | $85.04 | -$114.80K | SELL-OPTIONS | 17.45% | 9.17K | Aug 04 - Aug 07 | View |
| Jul 28, 2023 | James Edward Doyle | DIRECTOR | -2.00K | $97.42 | -$194.84K | SELL | -3.70% | 52.11K | Jul 27 | View |
| Jul 21, 2023 | James Herriott | GENERAL COUNSEL | -1.30K | $100.00 | -$130.00K | SELL | -15.96% | 6.84K | Jul 19 | View |
| Jun 12, 2023 | James Edward Doyle | DIRECTOR | 2.20K | $90.51 | -$126.90K | GRANT | 4.23% | 54.11K | Jun 08 - Jun 09 | View |
| Jun 12, 2023 | Katherine S Zanotti | DIRECTOR | 572.00 | $90.51 | -$273.97K | GRANT | 0.89% | 64.63K | Jun 08 - Jun 09 | View |
| Jun 12, 2023 | James Herriott | GENERAL COUNSEL | -1.30K | $90.00 | -$117.00K | SELL | -13.76% | 8.14K | Jun 08 | View |
| May 31, 2023 | James Edward Doyle | DIRECTOR | -2.00K | $80.62 | -$161.24K | SELL | -3.71% | 51.91K | May 26 | View |
| May 12, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -6.09K | $80.00 | -$486.96K | SELL | -6.63% | 85.74K | May 10 | View |
| May 12, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | -5.00K | $80.00 | -$400.00K | SELL | -40.86% | 7.24K | May 10 | View |
| May 12, 2023 | James Herriott | GENERAL COUNSEL | -660.00 | $54.93 | -$84.59K | SELL | -6.53% | 9.45K | May 01 - May 10 | View |
| May 03, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -291.00 | $46.90 | -$42.50K | SELL | -0.32% | 91.83K | Apr 30 - May 01 | View |
| Apr 05, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -1.00K | $67.19 | -$67.19K | SELL | -1.07% | 92.12K | Apr 03 | View |
| Mar 07, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | -5.00K | $65.00 | -$325.00K | SELL | -29.47% | 11.97K | Mar 03 | View |
| Mar 02, 2023 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | -3.63K | $62.01 | -$224.97K | SELL | -13.78% | 22.70K | Mar 01 | View |
| Mar 02, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -1.00K | $62.00 | -$62.00K | SELL | -1.07% | 92.85K | Mar 01 | View |
| Mar 01, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 4.90K | $61.12 | -$258.72K | SELL-OPTIONS | 19.15% | 30.51K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | James Herriott | GENERAL COUNSEL | -338.00 | $60.43 | -$134.45K | SELL | -3.32% | 9.84K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | -2.88K | $60.29 | -$411.87K | SELL | -14.50% | 16.97K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | D. Scott Coward | DIRECTOR | 5.04K | $61.12 | -$253.83K | SELL-OPTIONS | 15.67% | 37.20K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | 3.39K | $61.12 | -$178.71K | SELL-OPTIONS | 3.74% | 93.85K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 2.02K | $61.12 | -$118.08K | SELL-OPTIONS | 35.81% | 7.67K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Kevin T Conroy | PRESIDENT AND CEO | 12.08K | $61.12 | -$636.63K | SELL-OPTIONS | 0.99% | 1.23M | Feb 27 - Feb 28 | View |
| Feb 23, 2023 | Kevin T Conroy | PRESIDENT AND CEO | 5.61K | $62.72 | -$298.80K | SELL-OPTIONS | 0.46% | 1.22M | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | James Herriott | GENERAL COUNSEL | 467.00 | $62.72 | -$24.96K | SELL-OPTIONS | 4.81% | 10.17K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | 3.19K | $62.72 | -$169.97K | SELL-OPTIONS | 19.13% | 19.85K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | 1.22K | $62.72 | -$64.79K | SELL-OPTIONS | 1.36% | 90.46K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | D. Scott Coward | DIRECTOR | 1.24K | $62.72 | -$63.16K | SELL-OPTIONS | 4.01% | 32.16K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.68K | $62.72 | -$89.69K | SELL-OPTIONS | 7.03% | 25.60K | Feb 21 - Feb 22 | View |
| Feb 23, 2023 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 891.00 | $62.72 | -$52.56K | SELL-OPTIONS | 18.74% | 5.65K | Feb 21 - Feb 22 | View |
| Feb 17, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -1.08K | $63.91 | -$68.77K | SELL | -1.19% | 89.25K | Feb 16 | View |
| Feb 16, 2023 | James Herriott | GENERAL COUNSEL | 483.00 | $65.59 | -$26.24K | SELL-OPTIONS | 5.24% | 9.71K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | 1.08K | $65.59 | -$62.57K | SELL-OPTIONS | 1.21% | 90.32K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | Jacob A Orville | GENERAL MANAGER, SCREENING | 1.08K | $69.59 | -$66.39K | SELL-OPTIONS | 6.90% | 16.66K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | D. Scott Coward | DIRECTOR | 2.15K | $65.59 | -$119.44K | SELL-OPTIONS | 7.48% | 30.92K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.11K | $65.59 | -$122.39K | SELL-OPTIONS | 9.65% | 23.92K | Feb 14 - Feb 15 | View |
| Feb 16, 2023 | Kevin T Conroy | PRESIDENT AND CEO | 16.52K | $65.59 | -$958.73K | SELL-OPTIONS | 1.38% | 1.21M | Feb 14 - Feb 15 | View |
| Feb 14, 2023 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.42K | $64.55 | -$74.75K | SELL-OPTIONS | 6.97% | 21.82K | Feb 10 - Feb 13 | View |
| Feb 14, 2023 | Kevin T Conroy | PRESIDENT AND CEO | 5.18K | $64.55 | -$292.22K | SELL-OPTIONS | 0.44% | 1.19M | Feb 10 - Feb 13 | View |
| Feb 03, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -1.00K | $67.93 | -$67.93K | SELL | -1.11% | 89.25K | Feb 01 | View |
| Jan 11, 2023 | Sarah Condella | EVP, HUMAN RESOURCES | -672.00 | $53.70 | -$44.45K | SELL | -0.74% | 90.25K | May 02 - Jan 09 | View |
| Oct 13, 2022 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 18.65K | $39.39 | -$504.62K | SELL-OPTIONS | ∞ | 18.65K | May 02 - Oct 12 | View |
| Aug 08, 2022 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 1.73K | $47.12 | -$46.37K | SELL-OPTIONS | 57.09% | 4.75K | Aug 04 - Aug 05 | View |
| Jul 28, 2022 | Katherine S Zanotti | DIRECTOR | 0.00 | $27.66 | -$161.10K | SELL-OPTIONS | 0.00% | 64.06K | Jul 26 | View |
| Jul 06, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 321.00 | $44.08 | $15.27K | GRANT | 0.03% | 1.19M | May 02 - Jul 01 | View |
| Jul 01, 2022 | Katherine S Zanotti | DIRECTOR | -1.09K | $40.13 | -$43.58K | SELL | -1.67% | 64.06K | Jun 30 | View |
| Mar 02, 2022 | Sarah Condella | EVP, HUMAN RESOURCES | 3.06K | $76.69 | -$215.96K | SELL-OPTIONS | 3.50% | 90.68K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 15.59K | $76.69 | -$1.10M | SELL-OPTIONS | 1.66% | 952.71K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | D. Scott Coward | CHIEF LEGAL OFFICER | 4.38K | $76.69 | -$300.01K | SELL-OPTIONS | 27.26% | 20.43K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 4.41K | $76.69 | -$310.59K | SELL-OPTIONS | 27.74% | 20.32K | Feb 28 - Mar 01 | View |
| Mar 01, 2022 | Sarah Condella | SVP, HUMAN RESOURCES | -5.48K | $74.19 | -$406.54K | SELL | -5.89% | 87.62K | Feb 25 | View |
| Feb 25, 2022 | Sarah Condella | SVP, HUMAN RESOURCES | 5.48K | $70.10 | -$330.66K | SELL-OPTIONS | 6.25% | 93.10K | Feb 23 - Feb 24 | View |
| Feb 25, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 31.52K | $70.10 | -$1.90M | SELL-OPTIONS | 3.48% | 937.13K | Feb 23 - Feb 24 | View |
| Feb 25, 2022 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 6.93K | $70.10 | -$407.63K | SELL-OPTIONS | 76.01% | 16.05K | Feb 23 - Feb 24 | View |
| Feb 25, 2022 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 6.85K | $70.10 | -$413.38K | SELL-OPTIONS | 75.64% | 15.91K | Feb 23 - Feb 24 | View |
| Feb 25, 2022 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 5.48K | $70.10 | -$330.66K | SELL-OPTIONS | 55.53% | 15.35K | Feb 23 - Feb 24 | View |
| Feb 24, 2022 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.55K | $69.05 | -$107.51K | SELL-OPTIONS | 20.73% | 9.06K | Feb 22 - Feb 23 | View |
| Feb 24, 2022 | Sarah Condella | SVP, HUMAN RESOURCES | 1.12K | $69.05 | -$77.61K | SELL-OPTIONS | 1.30% | 87.62K | Feb 22 - Feb 23 | View |
| Feb 24, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 5.18K | $69.05 | -$358.23K | SELL-OPTIONS | 0.58% | 905.61K | Feb 22 - Feb 23 | View |
| Feb 24, 2022 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 1.12K | $69.05 | -$77.68K | SELL-OPTIONS | 12.83% | 9.87K | Feb 22 - Feb 23 | View |
| Feb 24, 2022 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 1.14K | $69.05 | -$76.58K | SELL-OPTIONS | 14.26% | 9.12K | Feb 22 - Feb 23 | View |
| Feb 23, 2022 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 1.90K | $73.42 | $143.31K | SELL-OPTIONS | 27.75% | 8.75K | Feb 18 - Feb 22 | View |
| Feb 16, 2022 | Sarah Condella | SVP, HUMAN RESOURCES | 1.09K | $78.94 | $84.39K | SELL-OPTIONS | 1.28% | 86.50K | Feb 14 - Feb 15 | View |
| Feb 16, 2022 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.13K | $78.94 | $164.83K | SELL-OPTIONS | 39.74% | 7.50K | Feb 14 - Feb 15 | View |
| Feb 16, 2022 | Kevin T Conroy | PRESIDENT AND CEO | 207.91K | $49.54 | $3.20M | SELL-OPTIONS | 30.02% | 900.42K | Feb 14 - Feb 15 | View |
| Feb 16, 2022 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 1.09K | $78.94 | $84.23K | SELL-OPTIONS | 18.93% | 6.85K | Feb 14 - Feb 15 | View |
| Feb 16, 2022 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 2.49K | $78.42 | $188.14K | SELL-OPTIONS | 45.26% | 7.98K | Apr 30 - Feb 15 | View |
| Nov 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -16.92K | $93.88 | -$1.59M | SELL | -2.41% | 686.11K | Nov 01 | View |
| Oct 05, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -17.08K | $93.64 | -$1.60M | SELL | -2.37% | 703.03K | Oct 01 | View |
| Sep 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -18.98K | $104.42 | -$1.98M | SELL | -2.57% | 720.11K | Sep 01 | View |
| Aug 04, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -19.97K | $107.50 | -$2.15M | SELL | -2.63% | 739.09K | Aug 02 | View |
| Aug 02, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | -38.16K | $107.31 | -$4.25M | SELL | -96.47% | 1.40K | Apr 30 - Jul 29 | View |
| Aug 02, 2021 | Katherine S Zanotti | DIRECTOR | -1.38K | $111.11 | -$153.44K | SELL | -2.27% | 59.54K | Jul 30 | View |
| Aug 02, 2021 | James Edward Doyle | DIRECTOR | -2.64K | $111.17 | -$293.49K | SELL | -8.13% | 29.83K | Jul 30 | View |
| Jul 06, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -7.78K | $123.43 | -$960.78K | SELL | -1.02% | 759.06K | Jul 01 | View |
| Jun 11, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | -3.17K | $66.81 | -$622.96K | SELL | -4.02% | 75.80K | Apr 30 - Jun 10 | View |
| Jun 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -12.38K | $111.00 | -$1.37M | SELL | -1.59% | 766.84K | Jun 01 | View |
| Jun 03, 2021 | Thomas Carey | DIRECTOR | -17.00K | $108.11 | -$1.84M | SELL | -76.26% | 5.29K | Jun 02 | View |
| May 05, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -18.91K | $97.91 | -$2.50M | SELL | -2.37% | 779.23K | Apr 30 - May 03 | View |
| Apr 05, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -22.75K | $132.30 | -$3.01M | SELL | -2.77% | 798.14K | Apr 01 | View |
| Mar 15, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 0.00 | $78.03 | -$4.49M | SELL-OPTIONS | 0.00% | 43.04K | Mar 11 | View |
| Mar 08, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | -11.73K | $121.33 | -$1.42M | SELL | -23.39% | 38.43K | Mar 05 | View |
| Mar 05, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | -2.63K | $135.02 | -$355.37K | SELL | -6.24% | 39.55K | Mar 03 | View |
| Mar 05, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | -2.66K | $135.02 | -$359.69K | SELL | -32.65% | 5.50K | Mar 03 | View |
| Mar 03, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 2.50K | $138.42 | -$349.37K | SELL-OPTIONS | 5.25% | 50.16K | Mar 01 - Mar 02 | View |
| Mar 03, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 795.00 | $139.24 | -$588.99K | SELL-OPTIONS | 1.92% | 42.14K | Mar 01 - Mar 02 | View |
| Mar 03, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 899.00 | $139.23 | -$574.46K | SELL-OPTIONS | 12.59% | 8.04K | Mar 01 - Mar 02 | View |
| Mar 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | 10.78K | $138.42 | -$1.36M | SELL-OPTIONS | 1.33% | 820.89K | Mar 01 - Mar 02 | View |
| Mar 03, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | 1.85K | $138.42 | -$232.41K | SELL-OPTIONS | 2.40% | 78.85K | Mar 01 - Mar 02 | View |
| Mar 02, 2021 | Michael S Wyzga | DIRECTOR | -8.91K | $78.55 | -$2.20M | SELL | -77.70% | 2.56K | Feb 26 | View |
| Mar 02, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 1.66K | $137.44 | -$220.32K | SELL-OPTIONS | 3.61% | 47.66K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | -4.97K | $136.91 | -$1.15M | SELL | -10.72% | 41.34K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | 1.26K | $137.44 | -$150.91K | SELL-OPTIONS | 1.66% | 77.01K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | James E. Doyle | DIRECTOR | -2.00K | $130.11 | -$260.22K | SELL | -6.16% | 30.46K | Feb 26 | View |
| Mar 02, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 1.76K | $90.67 | -$591.74K | SELL-OPTIONS | 32.84% | 7.14K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -21.98K | $136.88 | -$4.28M | SELL | -2.64% | 810.11K | Feb 26 - Mar 01 | View |
| Mar 01, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | -6.79K | $132.96 | -$902.53K | SELL | -55.81% | 5.37K | Feb 25 | View |
| Feb 25, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 5.73K | $136.30 | -$796.26K | SELL-OPTIONS | 14.24% | 46.00K | Feb 23 - Feb 24 | View |
| Feb 25, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 4.85K | $136.30 | -$606.40K | SELL-OPTIONS | 11.70% | 46.31K | Feb 23 - Feb 24 | View |
| Feb 25, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 6.79K | $79.07 | -$2.98M | SELL-OPTIONS | 126.31% | 12.16K | Feb 23 - Feb 24 | View |
| Feb 25, 2021 | Kevin T Conroy | PRESIDENT AND CEO | 17.91K | $136.30 | -$2.24M | SELL-OPTIONS | 2.20% | 832.09K | Feb 23 - Feb 24 | View |
| Feb 25, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | 2.24K | $136.30 | -$280.37K | SELL-OPTIONS | 3.05% | 75.75K | Feb 23 - Feb 24 | View |
| Feb 22, 2021 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 1.95K | $143.38 | -$243.17K | SELL-OPTIONS | 53.03% | 5.64K | Feb 18 - Feb 19 | View |
| Feb 22, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | -1.98K | $140.79 | -$278.76K | SELL | -26.92% | 5.37K | Feb 18 | View |
| Feb 18, 2021 | Jacob A Orville | GENERAL MANAGER, NEW VENTURES | 997.00 | $142.66 | -$147.37K | SELL-OPTIONS | 37.12% | 3.68K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | Graham P. Lidgard | CHIEF SCIENCE OFFICER | 1.84K | $142.66 | -$304.01K | SELL-OPTIONS | 4.79% | 40.27K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 1.95K | $142.66 | -$288.17K | SELL-OPTIONS | 4.94% | 41.46K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | D. Scott Coward | CHIEF ADMINISTRATIVE OFFICER | 1.98K | $142.66 | -$284.18K | SELL-OPTIONS | 36.84% | 7.35K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | Kevin T Conroy | PRESIDENT AND CEO | 15.31K | $142.66 | -$2.26M | SELL-OPTIONS | 1.92% | 814.19K | Feb 16 - Feb 17 | View |
| Feb 18, 2021 | Sarah Condella | SVP, HUMAN RESOURCES | 997.00 | $142.66 | -$147.37K | SELL-OPTIONS | 1.38% | 73.50K | Feb 16 - Feb 17 | View |
| Feb 03, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -66.09K | $138.07 | -$4.19M | SELL | -7.80% | 781.34K | Dec 28 - Feb 01 | View |
| Jan 07, 2021 | Kevin T Conroy | PRESIDENT AND CEO | -31.81K | $128.74 | -$4.10M | SELL | -3.62% | 847.43K | Jan 04 | View |
| Dec 14, 2020 | Katherine S Zanotti | — | -20.00K | $132.06 | -$2.64M | SELL | -25.35% | 58.91K | Dec 14 | View |
| Dec 02, 2020 | Kevin T Conroy | — | -30.58K | $124.56 | -$3.81M | SELL | -3.36% | 879.25K | Dec 01 | View |
| Nov 03, 2020 | Kevin T Conroy | — | -32.82K | $121.11 | -$3.97M | SELL | -3.48% | 909.82K | Nov 02 | View |
| Oct 02, 2020 | Kevin T Conroy | — | -27.43K | $103.55 | -$2.84M | SELL | -2.83% | 942.64K | Oct 01 | View |
| Sep 28, 2020 | Torsten Hoof | — | 0.00 | $60.77 | -$169.31K | OPTION EXERCISE | 0.00% | 2.02K | Sep 24 | View |
| Sep 02, 2020 | Kevin T Conroy | — | -19.93K | $75.03 | -$1.50M | SELL | -2.01% | 970.07K | Sep 01 | View |
| Aug 21, 2020 | Torsten Hoof | — | -6.45K | $64.15 | -$610.35K | OPTION EXERCISE | -76.17% | 2.02K | Aug 19 | View |
| Aug 04, 2020 | Thomas D Carey | — | -15.00K | $51.62 | -$2.73M | OPTION EXERCISE | -40.68% | 21.87K | Jul 31 | View |
| Aug 04, 2020 | Kevin T Conroy | — | -24.70K | $68.12 | -$2.34M | GRANT OR AWARD | -2.43% | 990.00K | Apr 30 - Aug 03 | View |
| Aug 04, 2020 | Jeffrey T. Elliott | — | -30.86K | $57.76 | -$3.37M | OPTION EXERCISE | -43.86% | 39.51K | Jul 31 | View |
| Aug 04, 2020 | Daniel J Levangie | — | 0.00 | $51.65 | -$835.61K | OPTION EXERCISE | 0.00% | 15.02K | Jul 31 | View |
| Aug 04, 2020 | Katherine S Zanotti | — | 0.00 | $51.26 | -$1.80M | OPTION EXERCISE | 0.00% | 78.91K | Jul 31 | View |
| Aug 04, 2020 | James Edward Doyle | — | -2.54K | $94.00 | -$238.67K | SELL | -7.25% | 32.46K | Jul 31 | View |
| Jul 30, 2020 | Jeffrey T. Elliott | — | 10.46K | $94.78 | $969.68K | GRANT OR AWARD | 17.47% | 70.37K | Oct 30 - Jul 29 | View |
| Jul 30, 2020 | Katherine S Zanotti | — | -1.16K | $96.13 | -$111.90K | SELL | -1.45% | 78.91K | Jul 28 | View |
| Apr 06, 2020 | Mark Stenhouse | — | 13.05K | $56.69 | -$677.33K | OPTION EXERCISE | 77.35% | 29.93K | Apr 02 - Apr 03 | View |
| Mar 03, 2020 | James Edward Doyle | — | -2.00K | $77.54 | -$155.08K | SELL | -5.81% | 32.44K | Feb 28 | View |
| Mar 02, 2020 | Jeffrey T. Elliott | — | 2.64K | $80.17 | -$191.05K | OPTION EXERCISE | 4.63% | 59.73K | Feb 27 - Feb 28 | View |
| Mar 02, 2020 | Kevin T Conroy | — | 10.82K | $80.17 | -$781.66K | OPTION EXERCISE | 1.08% | 1.01M | Feb 27 - Feb 28 | View |
| Feb 28, 2020 | Mark Stenhouse | — | 2.21K | $80.27 | -$84.36K | OPTION EXERCISE | 15.08% | 16.87K | Feb 26 - Feb 27 | View |
| Feb 28, 2020 | Jeffrey T. Elliott | — | 1.81K | $80.27 | -$130.60K | OPTION EXERCISE | 3.26% | 57.26K | Feb 26 - Feb 27 | View |
| Feb 28, 2020 | Kevin T Conroy | — | 15.46K | $80.27 | -$1.11M | OPTION EXERCISE | 1.56% | 1.00M | Feb 26 - Feb 27 | View |
| Feb 26, 2020 | Jeffrey T. Elliott | — | 4.39K | $85.11 | -$417.89K | OPTION EXERCISE | 8.60% | 55.45K | Feb 24 - Feb 25 | View |
| Feb 26, 2020 | Kevin T Conroy | — | 16.21K | $85.11 | -$1.54M | OPTION EXERCISE | 1.67% | 988.40K | Feb 24 - Feb 25 | View |
| Feb 21, 2020 | G. Bradley Cole | — | -10.00K | $67.88 | -$2.11M | OPTION EXERCISE | -49.52% | 10.19K | Feb 19 | View |
| Feb 20, 2020 | Jacob A Orville | — | 2.50K | $100.68 | -$116.08K | OPTION EXERCISE | 1299.48% | 2.69K | Feb 18 - Feb 19 | View |
| Jan 17, 2020 | G. Bradley Cole | — | -10.00K | $90.30 | -$903.00K | SELL | -32.27% | 20.99K | Jan 16 | View |
| Nov 25, 2019 | G. Bradley Cole | GENERAL MANAGER - DIAGNOSTICS | -28.02K | $80.38 | -$2.25M | SELL | -39.27% | 43.32K | Nov 21 | View |
| Sep 13, 2019 | Scott C Johnson | SVP - RESEARCH AND DEVELOPMENT | 4.66K | $69.54 | -$362.25K | SELL-OPTIONS | 59.39% | 12.50K | Apr 30 - Sep 12 | View |
| Aug 02, 2019 | Katherine S Zanotti | DIRECTOR | -1.74K | $117.93 | -$205.67K | SELL | -2.20% | 77.51K | Jul 31 | View |
| Aug 02, 2019 | Michael S Wyzga | DIRECTOR | -2.50K | $72.45 | -$522.20K | SELL | -21.90% | 8.91K | Jul 31 | View |
| Aug 02, 2019 | Daniel J Levangie | DIRECTOR | 0.00 | $61.48 | -$4.79M | SELL-OPTIONS | 0.00% | 12.46K | Jul 31 | View |
| Aug 02, 2019 | James Edward Doyle | DIRECTOR | -2.81K | $117.93 | -$331.15K | SELL | -7.54% | 34.44K | Jul 31 | View |
| Aug 02, 2019 | Thomas D Carey | DIRECTOR | -10.00K | $117.65 | -$1.18M | SELL | -22.63% | 34.18K | Jul 31 | View |
| Jul 31, 2019 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 9.27K | $83.10 | -$1.02M | SELL-OPTIONS | 22.29% | 50.88K | Apr 30 - Jul 30 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.